Source: Pharmabiz

Fresenius Kabi: Fresenius Kabi launches rocuronium bromide injection stable at room temperature

Fresenius Kabi, an operating company of Fresenius, and a leading provider of essential medicines and medical technologies, announced it has launched rocuronium bromide injection room temperature stable

Read full article »
Est. Annual Revenue
$5.0-10B
Est. Employees
10-50K
Pierluigi Antonelli's photo - President & CEO of Fresenius Kabi

President & CEO

Pierluigi Antonelli

CEO Approval Rating

- -/100

Read more